Literature DB >> 34101129

Pyoderma gangrenosum with primary sclerosing cholangitis-associated colitis successfully treated with concomitant granulocyte and monocyte adsorption apheresis with corticosteroids.

Munenori Kawai1, Chiharu Kawanami2, Akihisa Fukuda3, Hiroshi Seno3.   

Abstract

An 18-year-old woman was admitted to our hospital with fever, diarrhea and painful skin ulcers in both pretibial areas starting 19 days earlier. The skin lesions appeared deep necrotic ulcers with violaceous undermined borders. She had been diagnosed as ulcerative colitis and primary sclerosing cholangitis (PSC) 6 and 5 years before, respectively, and had stopped having regular check-up and refused medication for years. Her clinical history and skin lesions led us to suspect of pyoderma gangrenosum (PG). The skin biopsy showed aseptic abscess formation with neutrophils infiltration in the dermis without bacteria. Thus, she was diagnosed with PG. 1 mg/kg/day of prednisolone was administered and ten sessions of granulocyte and monocyte adsorption apheresis (GMA) were started. Magnetic resonance cholangiography showed multifocal bile duct strictures due to PSC. Total colonoscopy revealed ulcerative pancolitis with spared normal mucosa in the rectum. After the treatments, her symptoms and the skin lesion improved dramatically. She was discharged on the 45th day with 25 mg/day of prednisolone. In conclusion, this is the first reported case of PG with PSC-associated colitis that showed dramatic response to the concomitant GMA therapy with corticosteroids. Together with previous reports, concomitant GMA therapy with corticosteroids may be an effective treatment for PG.

Entities:  

Keywords:  Granulocyte and monocyte adsorption apheresis; Inflammatory bowel disease associated with primary sclerosing cholangitis; Primary sclerosing cholangitis; Pyoderma gangrenosum

Year:  2021        PMID: 34101129     DOI: 10.1007/s12328-021-01460-0

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  1 in total

1.  Granulocytapheresis as a possible cancer treatment.

Authors:  T Tabuchi; H Ubukata; S Sato; I Nakata; Y Goto; Y Watanabe; T Hashimoto; T Mizuta; M Adachi; T Soma
Journal:  Anticancer Res       Date:  1995 May-Jun       Impact factor: 2.480

  1 in total
  2 in total

Review 1.  Use of granulocyte and monocyte adsorption apheresis in dermatology (Review).

Authors:  Laura Gnesotto; Guido Mioso; Mauro Alaibac
Journal:  Exp Ther Med       Date:  2022-06-24       Impact factor: 2.751

Review 2.  Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease.

Authors:  Farah Yasmin; Hala Najeeb; Unaiza Naeem; Abdul Moeed; Thoyaja Koritala; Salim Surani
Journal:  World J Clin Cases       Date:  2022-07-26       Impact factor: 1.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.